US Stock MarketDetailed Quotes

TMCI Treace Medical Concepts

Watchlist
  • 7.380
  • +0.060+0.82%
Close May 6 16:00 ET
  • 7.330
  • -0.050-0.68%
Pre 07:31 ET
460.40MMarket Cap-8.20P/E (TTM)

Treace Medical Concepts Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
11.89%209.36M
10.44%68.71M
10.62%45.09M
5.96%44.46M
21.12%51.11M
31.92%187.12M
25.00%62.21M
23.30%40.76M
40.00%41.95M
45.26%42.2M
Operating revenue
11.89%209.36M
10.44%68.71M
10.62%45.09M
5.96%44.46M
21.12%51.11M
31.92%187.12M
25.00%62.21M
23.30%40.76M
40.00%41.95M
45.26%42.2M
Cost of revenue
16.80%41.09M
15.36%13.23M
11.95%8.95M
14.41%8.78M
25.97%10.13M
37.79%35.18M
27.14%11.47M
31.33%8M
45.06%7.68M
56.71%8.04M
Gross profit
10.75%168.26M
9.33%55.48M
10.29%36.13M
4.07%35.67M
19.98%40.98M
30.64%151.94M
24.53%50.74M
21.49%32.76M
38.91%34.28M
42.81%34.16M
Operating expense
10.12%223.95M
-3.21%55.68M
1.36%51.27M
20.55%57.06M
25.07%59.95M
34.55%203.37M
30.01%57.53M
32.12%50.58M
29.29%47.33M
49.73%47.93M
Selling and administrative expenses
8.21%203.36M
-5.44%50.47M
0.16%46.3M
18.48%51.9M
22.84%54.69M
36.61%187.93M
31.80%53.37M
34.06%46.23M
30.27%43.8M
53.72%44.52M
-Selling and marketing expense
4.79%147.64M
-7.68%36.86M
-2.29%32.78M
11.57%37.68M
19.83%40.33M
34.74%140.89M
32.68%39.92M
31.19%33.54M
26.92%33.77M
50.93%33.66M
-General and administrative expense
18.48%55.72M
1.21%13.61M
6.64%13.53M
41.74%14.22M
32.19%14.36M
42.52%47.03M
29.24%13.45M
42.28%12.69M
42.99%10.03M
63.09%10.87M
Research and development costs
33.35%20.59M
25.48%5.21M
14.09%4.96M
46.26%5.16M
54.13%5.26M
13.66%15.44M
10.75%4.15M
14.50%4.35M
18.16%3.53M
11.80%3.41M
Operating profit
-8.28%-55.69M
96.99%-204K
15.06%-15.13M
-63.82%-21.38M
-37.69%-18.97M
-47.59%-51.43M
-93.94%-6.78M
-57.43%-17.82M
-9.38%-13.05M
-70.16%-13.78M
Net non-operating interest income expense
-124.31%-379K
-202.47%-415K
-189.78%-246K
-90.67%64K
12.37%218K
150.53%1.56M
172.58%405K
135.58%274K
184.17%686K
120.59%194K
Non-operating interest income
-27.49%4.88M
-47.40%899K
-32.04%1.07M
-30.08%1.38M
3.79%1.54M
412.26%6.73M
126.96%1.71M
273.81%1.57M
1,402.29%1.97M
16,333.33%1.48M
Non-operating interest expense
1.72%5.26M
0.77%1.31M
1.31%1.31M
2.34%1.31M
2.49%1.32M
17.49%5.17M
-0.53%1.3M
8.91%1.3M
35.52%1.28M
35.12%1.29M
Other net income (expense)
-5.26%324K
22.92%118K
-13.04%20K
17.89%112K
-42.19%74K
107.00%342K
126.89%96K
151.11%23K
102.12%95K
6,300.00%128K
Special income (charges)
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-5.26%324K
22.92%118K
-13.04%20K
17.89%112K
-42.19%74K
184.86%342K
126.89%96K
151.11%23K
3,266.67%95K
6,300.00%128K
Income before tax
-12.55%-55.74M
92.02%-501K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-15.68%-49.53M
-42.36%-6.28M
-44.41%-17.52M
28.80%-12.27M
-48.89%-13.45M
Income tax
Net income
-12.55%-55.74M
92.02%-501K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-15.68%-49.53M
-42.36%-6.28M
-44.41%-17.52M
28.80%-12.27M
-48.89%-13.45M
Net income continuous Operations
-12.55%-55.74M
92.02%-501K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-15.68%-49.53M
-42.36%-6.28M
-44.41%-17.52M
28.80%-12.27M
-48.89%-13.45M
Minority interest income
Net income attributable to the parent company
-12.55%-55.74M
92.02%-501K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-15.68%-49.53M
-42.36%-6.28M
-44.41%-17.52M
28.80%-12.27M
-48.89%-13.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-12.55%-55.74M
92.02%-501K
12.33%-15.36M
-72.81%-21.21M
-38.81%-18.68M
-15.68%-49.53M
-42.36%-6.28M
-44.41%-17.52M
28.80%-12.27M
-48.89%-13.45M
Basic earnings per share
-11.11%-0.9
90.00%-0.01
10.71%-0.25
-70.00%-0.34
-30.43%-0.3
-5.19%-0.81
-25.00%-0.1
-27.27%-0.28
35.48%-0.2
-43.75%-0.23
Diluted earnings per share
-11.11%-0.9
90.00%-0.01
10.71%-0.25
-70.00%-0.34
-31.41%-0.3022
-5.19%-0.81
-25.00%-0.1
-27.27%-0.28
35.48%-0.2
-43.75%-0.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 11.89%209.36M10.44%68.71M10.62%45.09M5.96%44.46M21.12%51.11M31.92%187.12M25.00%62.21M23.30%40.76M40.00%41.95M45.26%42.2M
Operating revenue 11.89%209.36M10.44%68.71M10.62%45.09M5.96%44.46M21.12%51.11M31.92%187.12M25.00%62.21M23.30%40.76M40.00%41.95M45.26%42.2M
Cost of revenue 16.80%41.09M15.36%13.23M11.95%8.95M14.41%8.78M25.97%10.13M37.79%35.18M27.14%11.47M31.33%8M45.06%7.68M56.71%8.04M
Gross profit 10.75%168.26M9.33%55.48M10.29%36.13M4.07%35.67M19.98%40.98M30.64%151.94M24.53%50.74M21.49%32.76M38.91%34.28M42.81%34.16M
Operating expense 10.12%223.95M-3.21%55.68M1.36%51.27M20.55%57.06M25.07%59.95M34.55%203.37M30.01%57.53M32.12%50.58M29.29%47.33M49.73%47.93M
Selling and administrative expenses 8.21%203.36M-5.44%50.47M0.16%46.3M18.48%51.9M22.84%54.69M36.61%187.93M31.80%53.37M34.06%46.23M30.27%43.8M53.72%44.52M
-Selling and marketing expense 4.79%147.64M-7.68%36.86M-2.29%32.78M11.57%37.68M19.83%40.33M34.74%140.89M32.68%39.92M31.19%33.54M26.92%33.77M50.93%33.66M
-General and administrative expense 18.48%55.72M1.21%13.61M6.64%13.53M41.74%14.22M32.19%14.36M42.52%47.03M29.24%13.45M42.28%12.69M42.99%10.03M63.09%10.87M
Research and development costs 33.35%20.59M25.48%5.21M14.09%4.96M46.26%5.16M54.13%5.26M13.66%15.44M10.75%4.15M14.50%4.35M18.16%3.53M11.80%3.41M
Operating profit -8.28%-55.69M96.99%-204K15.06%-15.13M-63.82%-21.38M-37.69%-18.97M-47.59%-51.43M-93.94%-6.78M-57.43%-17.82M-9.38%-13.05M-70.16%-13.78M
Net non-operating interest income expense -124.31%-379K-202.47%-415K-189.78%-246K-90.67%64K12.37%218K150.53%1.56M172.58%405K135.58%274K184.17%686K120.59%194K
Non-operating interest income -27.49%4.88M-47.40%899K-32.04%1.07M-30.08%1.38M3.79%1.54M412.26%6.73M126.96%1.71M273.81%1.57M1,402.29%1.97M16,333.33%1.48M
Non-operating interest expense 1.72%5.26M0.77%1.31M1.31%1.31M2.34%1.31M2.49%1.32M17.49%5.17M-0.53%1.3M8.91%1.3M35.52%1.28M35.12%1.29M
Other net income (expense) -5.26%324K22.92%118K-13.04%20K17.89%112K-42.19%74K107.00%342K126.89%96K151.11%23K102.12%95K6,300.00%128K
Special income (charges) --0------------------0----------------
Other non- operating income (expenses) -5.26%324K22.92%118K-13.04%20K17.89%112K-42.19%74K184.86%342K126.89%96K151.11%23K3,266.67%95K6,300.00%128K
Income before tax -12.55%-55.74M92.02%-501K12.33%-15.36M-72.81%-21.21M-38.81%-18.68M-15.68%-49.53M-42.36%-6.28M-44.41%-17.52M28.80%-12.27M-48.89%-13.45M
Income tax
Net income -12.55%-55.74M92.02%-501K12.33%-15.36M-72.81%-21.21M-38.81%-18.68M-15.68%-49.53M-42.36%-6.28M-44.41%-17.52M28.80%-12.27M-48.89%-13.45M
Net income continuous Operations -12.55%-55.74M92.02%-501K12.33%-15.36M-72.81%-21.21M-38.81%-18.68M-15.68%-49.53M-42.36%-6.28M-44.41%-17.52M28.80%-12.27M-48.89%-13.45M
Minority interest income
Net income attributable to the parent company -12.55%-55.74M92.02%-501K12.33%-15.36M-72.81%-21.21M-38.81%-18.68M-15.68%-49.53M-42.36%-6.28M-44.41%-17.52M28.80%-12.27M-48.89%-13.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -12.55%-55.74M92.02%-501K12.33%-15.36M-72.81%-21.21M-38.81%-18.68M-15.68%-49.53M-42.36%-6.28M-44.41%-17.52M28.80%-12.27M-48.89%-13.45M
Basic earnings per share -11.11%-0.990.00%-0.0110.71%-0.25-70.00%-0.34-30.43%-0.3-5.19%-0.81-25.00%-0.1-27.27%-0.2835.48%-0.2-43.75%-0.23
Diluted earnings per share -11.11%-0.990.00%-0.0110.71%-0.25-70.00%-0.34-31.41%-0.3022-5.19%-0.81-25.00%-0.1-27.27%-0.2835.48%-0.2-43.75%-0.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.